EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning

Mesire Aydin iD, David C de Leeuw, Caroline E Rutten, Otto J Visser, Man Wai Tang iD, Cinthy van Roessel, Jeroen J W Janssen, Bart J Biemond iD, Arjan A van de Loosdrecht, Mette D Hazenberg iD, Ellen Meijer, Erfan Nur iD

British Journal of Haematology · 2023

DOI: 10.1111/bjh.19031 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Mesire Aydin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Transplantation Conditioning, Antilymphocyte Serum, Cyclophosphamide. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graft‐versus‐host disease (GvHD) is a serious complication of allogeneic haematopoietic stem cell transplantation (HSCT). Both anti‐thymocyte globulin (ATG) and post‐transplant cyclophosphamide (PTCy) are used as lymphocyte‐depleting strategies, yet a systematic comparison of transplantation outcomes between these two methods in matched unrelated donors (MUD) transplantations with non‐myeloablative conditioning (NMC) is lacking. Adult patients with haematological malignancies who had undergone MUD HSCT with NMC regimens between 2014 and 2021 at 2 centres in Amsterdam (ATG: n = 95, PTCy: n = 90), were included in this retrospective study. Patient characteristics were comparable between the groups. The cumulative incidence of acute GvHD grade II–IV was 48% in the ATG group compared to 21% in the PTCy group ( p < 0.001). The 3‐year moderate/severe chronic GvHD was similar in both groups ( p = 0.69). While the relapse rate was comparable between the groups (ATG 31% vs. PTCy 34%, p = 0.94), non‐relapse mortality tended to be higher in the ATG group (17% vs. 9%, p = 0.069). Overall survival was similar in both groups ( p = 0.12). In conclusion, PTCy‐based regimens resulted in a significantly lower rate of acute GvHD than ATG‐containing regimens in MUD transplantations with NMC. Whether PTCy results in improved overall survival as compared to ATG needs to be elucidated in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationTransplantation ConditioningAntilymphocyte SerumCyclophosphamideHematologic NeoplasmsHumansMaleFemaleMiddle AgedGraft vs Host DiseaseAdultUnrelated DonorsRetrospective StudiesAgedYoung AdultAdolescentSurvival Rate

Stichwörter der Autor:innen

allogeneicanti-thymocyte globulinin vivomatched unrelated donorpost-transplantation cyclophosphamide

Substanzen

Antilymphocyte SerumCyclophosphamide

Autor:innen und Institutionen

  • Department of Hematology, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Hematology, Amsterdam University Medical Centers, Location VU Medical Center, Free University, Amsterdam, the Netherlands.
  • Department of Hematology, Isala Hospital, Zwolle, the Netherlands.
  • Department or Blood Cell Research, Sanquin Research, Amsterdam, the Netherlands.

ORCID-Profile: Mesire Aydin, Man Wai Tang, Bart J Biemond, Mette D Hazenberg, Erfan Nur

Zitieren

APA

Aydin, M., de Leeuw, D. C., Rutten, C. E., Visser, O. J., Tang, M. W., van Roessel, C., Janssen, J. J. W., Biemond, B. J., van de Loosdrecht, A. A., Hazenberg, M. D., Meijer, E., & Nur, E. (2023). ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning. British Journal of Haematology. https://doi.org/10.1111/bjh.19031

Vancouver

Aydin M, de Leeuw DC, Rutten CE, Visser OJ, Tang MW, van Roessel C, et al. ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning. British Journal of Haematology. 2023. doi:10.1111/bjh.19031

BibTeX
@article{Aydin2023,
  author = {Aydin, Mesire and de Leeuw, David C and Rutten, Caroline E and Visser, Otto J and Tang, Man Wai and van Roessel, Cinthy and Janssen, Jeroen J W and Biemond, Bart J and van de Loosdrecht, Arjan A and Hazenberg, Mette D and Meijer, Ellen and Nur, Erfan},
  title = {ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.19031}
}
Kostenlos starten →